stella
beta
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma — Stella
Recruiting
Back to Soft Tissue Sarcoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Memorial Sloan Kettering Cancer Center, New York, New York
View full record on ClinicalTrials.gov